-
-
-
-
-
-
-
Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 5, 2025
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) Misses Q1 EPS by 313c; offers guidance
-
-
-
-
-
-
-
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
-
-
-
-
-
-
-
Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
-
-
-
-
-
-
-
Ligand Reports Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

